News
21 July 2026
Strengthening the Government’s Preventive Health Efforts, Sustainable Health Program Reaches More Than 16,500 People
JAKARTA – More than 16,500 people across Indonesia have participated in the Cek Kesehatan Segitiga, a free health screening program organized by Dexa Medica through Dharma Dexa since 2024. Beyond providing blood pressure, blood glucose, and cholesterol screenings, the program, now conducted at 22 locations, also integrates health education, medical…
14 July 2026
Supporting the National Health Program, Cek Segitiga Serves More Than 15,000 People
Surabaya – Through Dharma Dexa, Dexa Medica continues to implement Cek Segitiga, a free community health screening program that supports the Indonesian government’s efforts to strengthen the early detection of non-communicable diseases (NCDs). Since its launch in 2024, the program has reached more than 15,000 people through blood pressure, blood…
8 July 2026
OGB Merah at HISFARSI 2026: Reflecting Quality, Strengthening Trust
The quality of generic medicines can be demonstrated both through the production process and through the trust placed in them by healthcare professionals who use them in their practice. Building on this commitment, PT Dexa Medica presented "OGB Merah, A Reflection of Quality Generic Medicine" at the HISFARSI 2026 National…
3 November 2025
Dexa Medica Contributes to Supporting the Health Minister’s Target of 70 Million Indonesians Receiving Free Health Screenings by 2025
Minister of Health Budi Gunadi Sadikin has set a target for 60–70 million Indonesians to receive free health screenings by 2025. In support of this initiative, PT Dexa Medica continues to contribute through its Cek Segitiga Gratis program, which recently took place at the Car Free Day area on Boulevard…
27 October 2025
WHO and BPOM Recognize DLBS Phytopharmaceutical Innovation as a Global Benchmark in Green Pharmacy
Cikarang, October 16th, 2025 - A delegation from the World Health Organization (WHO) and Indonesia’s National Agency for Drug and Food Control (BPOM RI) visited Dexa Laboratories of Biomolecular Sciences (DLBS) to observe firsthand how Indonesia’s biodiversity is being utilized in pharmaceutical research for the development of Modern Indonesian Natural…
16 October 2025
30,000 Medicinal Plants, Only 20 Phytopharmaceuticals: Dexa Medica Strengthens Indonesia’s Role at the 16th WHO–IRCH Global Forum
Dexa Medica once again demonstrates its strong commitment as a national pharmaceutical company that plays a vital role in strengthening Indonesia’s pharmaceutical independence, particularly through the development of natural-based medicines. This commitment was reflected in its active contribution to the prestigious 16th Annual Meeting of the WHO–International Regulatory Cooperation for…
2 October 2025
Dexa Group Receives Two Prestigious Awards in One Day for Its Commitment to Halal Assurance Across All Products and Facilities
Dexa Group achieved a remarkable milestone by receiving two prestigious awards in a single day, underscoring its commitment to ensuring halal assurance across all products and facilities. The recognitions came from Indonesia’s Ministry of Industry (Kemenperin) and the Halal Inspection Body of the Institute for Food, Drug, and Cosmetic Studies…
2 October 2025
More Than 1,500 Residents Join Dexa Medica’s Free Health Check, Reinforcing Commitment to Quality and Halal Medicine Access
Non-Communicable Diseases (NCDs) such as hypertension, diabetes, and high cholesterol are increasingly becoming a threat to public health in Indonesia. These three silent killers often show no symptoms, yet have serious impacts on quality of life and healthcare costs. Responding to this challenge, PT Dexa Medica, through its Cek Segitiga…
24 September 2025
Building Reputation through The Reflection of Quality, Dexa Medica Wins Indonesia Most Reputable Companies Award 2025
Dexa Medica has once again received the prestigious Indonesia Most Reputable Companies Award 2025 from SWA Magazine and Business Digest. This marks the second time Dexa Medica has earned this recognition, reaffirming the company’s commitment to building and maintaining its reputation as a reflection of quality. The award was presented…
24 September 2025
Reflection of Quality and Innovation in Industry 4.0, Dexa Medica Wins Rintek 2025 Award
Dexa Medica has been awarded the 2025 Industrial Technology Pioneer Award (Rintek) in the category of Technology Pioneer Evaluation Results by the Ministry of Industry of the Republic of Indonesia. The award recognizes the success of Inlacin, an Indonesian Original Modern Medicine for diabetes, as a clinically proven global innovation…